Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Actelion
Pharma
Idorsia wins its first FDA approval with insomnia drug Quviviq
Idorsia's sleeping pill Quviviq will not reach the market until May because the FDA has suggested it be registered as a controlled substance.
Kevin Dunleavy
Jan 10, 2022 7:57am
Biopharma's M&A appetite remains, say J&J and Takeda execs
Jun 9, 2020 11:31am
India export, Roche's Actemra, Takeda and more—FiercePharmaAsia
Mar 6, 2020 10:20am
Top 10 pharma settlements since 2018
Nov 19, 2019 6:00am
J&J's Gorsky says military service shaped his leadership style
Apr 19, 2019 10:52am
Actelion inks $360M deal to wrap DOJ kickbacks probe
Dec 6, 2018 12:41pm
